Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine [version 1; peer review: 1 approved, 2 approved with reservations]
Background: Porphyria cutanea tarda (PCT) is a complex metabolic disease resulting from altered activity of the enzyme uroporphyrinogen decarboxylase (UROD) in the liver resulting in accumulation of uroporphyrin. PCT presents as a blistering photodermatitis with skin fragility, vesicles, scarring an...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
F1000 Research Ltd
2022-08-01
|
| Серии: | F1000Research |
| Предметы: | |
| Online-ссылка: | https://f1000research.com/articles/11-945/v1 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|